Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography

International Journal of Gynecological Cancer

Volumn 22, Issue 9, 2012, Pages 1532-1537

  Rajasooriyar, Chrishanthi ^a   Van Dyk, Sylvia ^b   Lindawati, Mery ^c   Bernshaw, David ^b   Kondalsamy Chennakesavan, Srinivas ^d   Narayan, Kailash ^b  

^a Teaching Hospital   (Sri Lanka)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF INDONESIA   (Indonesia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Cervical cancer; FIGO stage; Lymph node metastasis; Parametrial boost

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CLINICAL PRACTICE; EXTERNAL BEAM RADIOTHERAPY; EXTRAPELVIC FAILURE; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT SELECTION; PELVIC DISEASE; PELVIC FAILURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PELVIS; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY, IMAGE-GUIDED; RETROSPECTIVE STUDIES; TREATMENT FAILURE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84872305184     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31826c4dee     Document Type: Article

References (17)

1. Girardi F, Lichtenegger W, Tamussino K, et al. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol Oncol. 1989;34:206-211.
2. Wolfson AH, Abdel-Wahab M, Markoe AM, et al. A quantitative assessment of standard vs. customized midline shield construction for invasive cervical carcinoma. Int J Radiat Oncol Biol Phys. 1997;37:237-242.
3. Narayan K, van Dyk S, Bernshaw D, et al. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival. Int J Radiat Oncol Biol Phys. 2009;74:1529-1535.
4. Narayan K, Fisher RJ, Bernshaw D, et al. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent. Int J Gynecol Cancer. 2009;19:912-918.
5. Rajasooriyar C, van Dyk S, Bernshaw D, et al. Patterns of failure and treatment-related toxicity in advanced cervical cancer patients treated using extended field radiotherapy with curative intent. Int J Radiat Oncol Biol Phys. 2010.
6. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
7. Lagasse LD, Creasman W, Shingleton HM, et al. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol. 1980;9:90-98.
8. Burghardt E, Winter R, Tamussino K, et al. Diagnosis and surgical treatment of cervical cancer. Crit Rev Oncol Hematol. 1994;17:181-231.
9. Narayan K, Fisher RJ, Bernshaw D. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent. Int J Gynecol Cancer. 2008;18:525-533.
10. Kodaira T, Fuwa N, Toita T, et al. Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy. Int J Radiat. Oncol Biol Phys. 2003;56:769-777.
11. Eifel PJ, Morris M, Wharton JT, et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1994;29:9-16.
12. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43:763-775.
13. Huang EY, Lin H, Hsu HC, et al. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Gynecol Oncol. 2000;79:406-410.
14. Sun LM, Huang EY, Ko SF, et al. Computer Tomography-assisted three-dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer. Radiother Oncol. 2004;71:333-337.
15. Hamberger AD, Unal A, Gershenson DM, et al. Analysis of the severe complications of irradiation of carcinoma of the cervix: whole pelvis irradiation and intracavitary radium. Int J Radiat Oncol Biol Phys. 1983;9:367-371.
16. Fenkell L, Assenholt M, Nielsen SK, et al. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2011;79:1572-1579.
17. Atahan IL, Onal C, Ozyar E, et al. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer. 2007;17:833-842.